Millennium Pharmaceuticals Announces Webcast of Presentation at CIBC World Markets Biotechnology Conference

Apr 30, 2001, 01:00 ET from Millennium Pharmaceuticals, Inc.

    CAMBRIDGE, Mass., April 30 /PRNewswire/ -- Millennium Pharmaceuticals,
 Inc. (Nasdaq:   MLNM) announced today that its presentation to the CIBC World
 Markets Biotechnology Conference will be webcast live and may be accessed at
 http://webcast.talkpoint.com/starthere.asp?pres=13701&template=cibc&exit=htt
 p://www.mlnm.com/.
 
     Millennium senior management will provide a technology overview of the
 Company. The presentation will be delivered at 10:25 a.m. (Eastern Time) on
 Wednesday, May 2, from the Millennium Broadway Hotel in New York City.
 
     Millennium, a leading biopharmaceutical company, applies its comprehensive
 and integrated science and technology platform for the discovery and
 development of breakthrough therapeutic and predictive medicine products, with
 a goal of delivering personalized medicine. Through the industrialization of
 this gene-to-patient platform, Millennium is also striving to accelerate the
 process of drug discovery and development. Headquartered in Cambridge,
 Massachusetts, Millennium currently employs more than 1,300 people.
 
     Editor's Note: This release is available on Millennium's website at
 www.millennium.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X33437455
 
 

SOURCE Millennium Pharmaceuticals, Inc.
    CAMBRIDGE, Mass., April 30 /PRNewswire/ -- Millennium Pharmaceuticals,
 Inc. (Nasdaq:   MLNM) announced today that its presentation to the CIBC World
 Markets Biotechnology Conference will be webcast live and may be accessed at
 http://webcast.talkpoint.com/starthere.asp?pres=13701&template=cibc&exit=htt
 p://www.mlnm.com/.
 
     Millennium senior management will provide a technology overview of the
 Company. The presentation will be delivered at 10:25 a.m. (Eastern Time) on
 Wednesday, May 2, from the Millennium Broadway Hotel in New York City.
 
     Millennium, a leading biopharmaceutical company, applies its comprehensive
 and integrated science and technology platform for the discovery and
 development of breakthrough therapeutic and predictive medicine products, with
 a goal of delivering personalized medicine. Through the industrialization of
 this gene-to-patient platform, Millennium is also striving to accelerate the
 process of drug discovery and development. Headquartered in Cambridge,
 Massachusetts, Millennium currently employs more than 1,300 people.
 
     Editor's Note: This release is available on Millennium's website at
 www.millennium.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X33437455
 
 SOURCE  Millennium Pharmaceuticals, Inc.